NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1488,794$11.44
$1.02MBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1314,950$11.63
$173.87kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-128,971$11.86
$106.40kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-119,593$10.95
$105.04kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-10574$10.90
$6.26kBuy
Fairmount Funds Management LLCDirector2024-09-11275,000$23.00
$6.33MBuy
Janus Henderson Group PLC10% Owner2024-08-165,390$2.93
$15.79kBuy
Janus Henderson Group PLC10% Owner2024-08-16428$2.98
$1.27kBuy
Janus Henderson Group PLC10% Owner2024-07-2530,227$3.05
$92.28kBuy
Janus Henderson Group PLC10% Owner2024-07-247,056$3.16
$22.28kBuy

1 of 3

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Harry R. Weller27.30%10,221,465$97.51MInsider
Krishna Kittu Kolluri27.30%10,221,465$97.51MInsider
Ravi Viswanathan27.30%10,221,465$97.51MInsider
Joshua Makower27.30%10,221,465$97.51MInsider
Anthony A. Florence Jr.27.30%10,221,465$97.51MInsider
Peter W. Sonsini27.30%10,221,465$97.51MInsider
Peter J. Barris27.30%10,221,465$97.51MInsider
David M. Mott27.30%10,221,465$97.51MInsider
Forest Baskett27.30%10,221,465$97.51MInsider
Jon Sakoda27.30%10,221,465$97.51MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA16.86%83.14%Net BuyingNet Buying
OMER45.74%6.73%
AUTL63.24%0.00%
RGNX77.11%22.89%Net SellingNet Buying
VSTM40.67%59.33%Net SellingNet Selling

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 82.90% institutional shareholders, 408.80% Oruka Therapeutics insiders, and 0.00% retail investors. Harry R. Weller is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 27.30% of the company. Harry R. Weller's Oruka Therapeutics shares are currently valued at $99.66M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.